Tvardi Therapeutics, Inc. Common Stock

$2.63
-0.03 (-1.13%)

Volume:

34.992K ($92.03K)

Market Capitalization:

$24.67M

Tvardi Therapeutics Price Chart

Tvardi Therapeutics Price Chart11:59 AM1:19 PM2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM2.692.682.672.662.652.642.63

Tvardi Therapeutics Volume Chart

Tvardi Therapeutics Volume Chart11:59 AM1:19 PM2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM4.49K3.85K3.21K2.57K1.93K1.28K642

Tvardi Therapeutics Market Segments

Overnight

*No Trades in Segment

After Hours

+0.00(+0.00%)
Open$2.63
Close$2.63
Low$2.63
Low Change0.00 (0.00%)
High$2.63
High Change+0.00 (+0.00%)
Range$0.00
Volume4.492K
Dollar Volume$11.81K

Regular Trading Hours

+0.00(+0.00%)
Open$2.63
Close$2.63
Low$2.57
Low Change-0.06 (-2.28%)
High$2.69
High Change+0.06 (+2.28%)
Range$0.12
Volume30.5K
Dollar Volume$80.22K

Premarket

*No Trades in Segment

After Hours Yesterday

+0.05(+1.87%)
Open$2.67
Close$2.72
Low$2.67
Low Change0.00 (0.00%)
High$2.72
High Change+0.05 (+1.87%)
Range$0.05
Volume3.658K
Dollar Volume$9.95K

Regular Trading Hours Yesterday

+0.02(+0.76%)
Open$2.64
Close$2.66
Low$2.60
Low Change-0.04 (-1.52%)
High$2.79
High Change+0.15 (+5.68%)
Range$0.19
Volume64.411K
Dollar Volume$171.33K

Premarket Yesterday

*No Trades in Segment

Tvardi Therapeutics Moving Averages

5 Day Moving Average (SMA5)$2.69
10 Day Moving Average (SMA10)$2.83
20 Day Moving Average (SMA20)$3.19
50 Day Moving Average (SMA50)$3.30
100 Day Moving Average (SMA100)$3.53
200 Day Moving Average (SMA200)$8.75

Tvardi Therapeutics Statistics

Average Volume (30 Days)54.01K
P/E Ratio (Current)-1.62
EPS (Current)-$1.65
Dividend Yield0.00%
Free Cash Flow
Cash Ratio1.76
Current Ratio2.25
Quick Ratio2.25
Debt to Equity0.00
Enterprise Value$5.20M
EV to EBITDA-0.18
EV to Sales
Price to Book1.73
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-0.60%
Return on Equity-1.06%

Tvardi Therapeutics Stock Splits

There have been no stock splits for Tvardi Therapeutics (TVRD).

Tvardi Therapeutics Dividends

There have been no dividends for Tvardi Therapeutics (TVRD).